therascreen Solid Tumor
Trusted portfolio of solid tumor assays
Reliable detection and quantification of mutations and other cancer related genomic variants requires optimized detection kits that deliver confident results. We provide a trusted portfolio of solid tumor assays, enabling rapid and sensitive detection for your oncogene analyses. Our portfolio includes assays for both FFPE and liquid biopsy analysis.
Produits
Sort
Detection
Gene analyzed
Regulatory status
24 produits trouvés
PIK3CA RGQ PCR Kit
For qualitative detection of 11 mutations in the PIK3CA gene by real-time PCR
therascreen EGFR RGQ PCR Kit version 2
For sensitive detection of the most frequently occurring somatic mutations in the EGFR oncogene in less than 4 hours
therascreen PIK3CA RGQ PCR Kit (CE-IVD)
For qualitative detection of 11 mutations in the PIK3CA gene by real-time PCR
therascreen RAS Extension Pyro Kit
For quantitative detection of mutations in exons 3, and 4 of the human KRAS oncogene, and exons 2, 3, and 4 of the human NRAS oncogene
therascreen KRAS Pyro Kit
Pour la détection et la quantification de mutations du gène KRAS par séquençage
therascreen MGMT Pyro Kit
Pour la mesure quantitative de l’état de méthylation de l’exon 1 du gène MGMT humain
therascreen KRAS RGQ PCR Kit
For qualitative detection of mutations in the KRAS oncogene using real-time PCR
therascreen FGFR RGQ RT-PCR Kit version 2
For qualitative detection of actionable alterations in the FGFR3 gene
therascreen BRAF Pyro Kit
Pour la détection et la quantification de mutations de l’oncogène BRAF par séquençage
therascreen EGFR Pyro Kit
Pour la détection et la quantification de mutations du gène EGFR par séquençage
therascreen BRAF V600E RGQ PCR Kit
For qualitative detection of V600E mutations in the BRAF gene using real-time PCR
therascreen BRAF RGQ PCR Kit CE
Pour la détection de mutations somatiques de l’oncogène BRAF
therascreen IDH1/2 RGQ PCR Kit CE
Pour la détection de 12 mutations des gènes IDH1 et IDH2 dans les gliomes
therascreen KRAS RGQ PCR Kit
pour la détection de 7 mutations somatiques de l’oncogène KRAS.
therascreen EGFR Plasma RGQ PCR Kit
For sensitive detection of clinically proven somatic mutations in the EGFR oncogene, on cfDNA (circulating-free DNA) extracted from plasma samples
RAS Extension Pyro Kit
For quantitative detection of mutations in exons 3, and 4 of the human KRAS oncogene, and exons 2, 3, and 4 of the human NRAS oncogene
therascreen NRAS Pyro Kit
Pour la détection et la quantification de mutations de l’oncogène NRAS par séquençage
IDH1/2 RGQ PCR Kit
For the detection of 12 IDH1 and IDH2 mutations in DNA from FFPE brain tumor tissue
therascreen GIST RapidScreen Pyro Kit
Pour la détection quantitative de mutations des gènes humains KIT et PDGFRA
therascreen PITX2 RGQ PCR Kit
For clinically reliable determination of the PITX2 methylation ratio in lymph node-positive, estrogen receptor-positive and HER2-negative high-risk breast cancer patient tissue samples
therascreen UGT1A1 Pyro Kit
Pour le génotypage des variants alléliques *28 et *6 du gène UGT1A1 humain.
EGFR Plus RGQ PCR Kit
For qualitative detection and identification of mutations in exons 18, 19, 20 and 21 of the EGFR gene
therascreen KRAS RGQ PCR Kit
For qualitative detection of mutations in the KRAS oncogene using real-time PCR
therascreen EGFR Plus RGQ PCR Kit
For detection and identification of 42 mutations in exons 18, 19, 20 and 21 of the EGFR gene
Related News and Support
Stay up-to-date with My QIAGEN
Manage your orders, quotes, webinars, instruments and other items of interest.
Our stories
Explore our digital magazine full of customer stories and videos on scientific breakthroughs and healthcare advances.
Ordering from QIAGEN
Learn about easy ordering options that offer fast and reliable delivery.